' Alarming ' Decrease in Survival as Surgery Underused in mRCC ' Alarming ' Decrease in Survival as Surgery Underused in mRCC

Cytoreductive nephrectomy in patients with metastatic renal cancer has been underutilized since the advent of targeted therapy, despite lack of hard evidence that survival is not adversely affected.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news